Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July
NAIROBI/DAKAR - Lead vaccine candidates developed by Oxford University and Moderna against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congol, could enter Phase 1 trials as early as July, with field trials possible within several months, the head of the Coalition for Epidemic Preparedness Innovations, Richard Hatchett, said on Tuesday.
(Reporting by Anait Miridzhanian and Emma Farge; Editing by Alison Williams)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published June 16, 2026 at 9:20 AM.